Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.685 USD | +1.32% | +16.13% | -36.28% |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
04-25 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.28% | 594M | |
+20.38% | 42.68B | |
-2.97% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.93% | 24.94B | |
-19.84% | 18.96B | |
+30.18% | 12.3B | |
-2.73% | 11.95B | |
-2.89% | 11.55B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Earnings Flash (CVAC) CUREVAC Posts Q2 Revenue EUR22.4M